QHSLab, Inc.
USAQ · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.20 | 0.03 | -0.12 | -0.09 |
| FCF Yield | 5.58% | -18.83% | -26.30% | -8.88% |
| EV / EBITDA | 11.68 | -28.23 | -6.85 | -13.84 |
| Quality | ||||
| ROIC | 18.46% | -17.08% | -31.94% | -23.59% |
| Gross Margin | 63.69% | 56.32% | 49.83% | 47.42% |
| Cash Conversion Ratio | -0.55 | 0.34 | 0.35 | 0.46 |
| Growth | ||||
| Revenue 3-Year CAGR | 19.70% | -0.13% | 115.32% | – |
| Free Cash Flow Growth | 189.23% | 58.87% | 23.80% | -158.19% |
| Safety | ||||
| Net Debt / EBITDA | 4.44 | -18.95 | -3.45 | -2.08 |
| Interest Coverage | 0.44 | -1.04 | -1.29 | -2.04 |
| Efficiency | ||||
| Inventory Turnover | 18.53 | 24.44 | 12.03 | 11.31 |
| Cash Conversion Cycle | -107.51 | -13.37 | -5.83 | 40.45 |